4 Results for "

mutation-positive

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "mutation-positive" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-123921
CAS No.: 2230821-27-7
Purity:  99.98%
Target:  

PROTACs EGFR

Research Areas:  

Cancer

Gefitinib-based PROTAC 3 is a PROTAC degrader targeting EGFR, with a DC50 of 11.7 nM against exon 19 deletion mutants and a DC50 of 22.3 nM against EGFR L858R. Gefitinib-based PROTAC 3 selectively induces the ubiquitin-proteasome degradation of exon 19 deletion-mutant and L858R-mutant EGFR by recruiting the VHL E3 ligase. Gefitinib-based PROTAC 3 can be used for the research of EGFR mutation-positive cancers .
loading...
    loading...
Cat. No.: HY-123319
CAS No.: 873888-67-6
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Antofloxacin hydrochloride is a well tolerate, orally active and broad-spectrum 8-amino-fluoroquinolone with potent antibacterial activities. Antofloxacin hydrochloride shows superior antibacterial activity against gyrA mutation-positive H. pylori strains, especially in Asn87- mutated strains, compared to levofloxacin. Antofloxacin hydrochloride is a weak, reversible inhibitor of CYP1A2 for the research of infections caused by a diverse group of bacterial species .
loading...
    loading...
Cat. No.: HY-123319A
CAS No.: 119354-43-7
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Antofloxacin is a well tolerate, orally active and broad-spectrum 8-amino-fluoroquinolone with potent antibacterial activities. Antofloxacin shows superior antibacterial activity against gyrA mutation-positive H. pylori strains, especially in Asn87- mutated strains, compared to levofloxacin. Antofloxacin is a weak, reversible inhibitor of CYP1A2 for the research of infections caused by a diverse group of bacterial species .
loading...
    loading...
Cat. No.: HY-175473
CAS No.: 898168-15-5
Target:  

FLT3 Apoptosis

Research Areas:  

Cancer

HI042 is a FMS-like Tyrosine Kinase 3 (FLT3) inhibitor. HI042 shows IC50 values of 0.62 μM for MOLM-13, 0.33 μM for MV4-11, and 0.89 μM for OCI-AML3 cells. HI042 selectively reduces the viability of FLT3-internal tandem duplication (FLT3-|TD) mutations-positive cell lines, induces apoptosis, disrupts cell cycle progression, and diminishes the clonogenic potential. HI042 can be used for the research of acute myeloid leukemia (AML) .
loading...
    loading...